Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CaraClear: Stem Cell-Fortified Eye Drops for Dry Eye and Cataract
NCT07191847Phase 4Recruiting
- Sponsor
- Ace Cells Lab
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in dry eye disease (DED) and cataract, sponsored by Ace Cells Lab. Primary endpoint: Slit-lamp grading + AS-OCT (structural clarity) at 12 weeks. Started Apr 2025; status: recruiting.
02
Conditions
dry eye disease (DED)cataract
Beyond the preview
Go deeper on NCT07191847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07191847.